<?xml version="1.0" encoding="UTF-8"?>
<ref id="B70-biomolecules-10-01625">
 <label>70.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nayak</surname>
    <given-names>S.U.</given-names>
   </name>
   <name>
    <surname>Griffiss</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Blumer</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Oâ€™Riordan</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Gray</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>McKenzie</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Jurao</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>An</surname>
    <given-names>A.T.</given-names>
   </name>
   <name>
    <surname>Le</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bell</surname>
    <given-names>S.J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of 
   <italic>Clostridium difficile</italic>, in a Phase 1 Study
  </article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2017</year>
  <volume>61</volume>
  <fpage>e02760-16</fpage>
  <pub-id pub-id-type="doi">10.1128/AAC.02760-16</pub-id>
  <?supplied-pmid 28584140?>
  <pub-id pub-id-type="pmid">28584140</pub-id>
 </element-citation>
</ref>
